The DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
The S100B story: from biomarker to active factor in neural injury
Open accessAbstract
S100B is a Ca 2+‐binding protein mainly concentrated in astrocytes. Its levels in biological fluids (cerebrospinal fluid, peripheral and cord blood, urine, saliva, amniotic fluid) are recognized as a reliable biomarker of active neural distress. Although the wide spectrum of diseases in which the protein is involved (acute brain injury, neurodegenerative diseases, congenital/perinatal disorders, psychiatric disorders) reduces its specificity, its levels remain an important aid in monitoring the trend of the disorder. Mounting evidence now points to S100B as a Damage‐Associated Molecular Pattern molecule which, when released at high concentration, through its Receptor for Advanced Glycation Endproducts, triggers tissue reaction to damage in a series of different neural disorders. This review addresses this novel scenario, presenting data indicating that S100B levels and/or distribution in the nervous tissue of patients and/or experimental models of different neural disorders, for which the protein is used as a biomarker, are directly related to the progress of the disease: acute brain injury (ischemic/hemorrhagic stroke, traumatic injury), neurodegenerative diseases (Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis), congenital/perinatal disorders (Down syndrome, spinocerebellar ataxia‐1), psychiatric disorders (schizophrenia, mood disorders), inflammatory bowel disease. In many cases, over‐expression/administration of the protein induces worsening of the disease, whereas its deletion/inactivation produces amelioration. This review points out that the pivotal role of the protein resulting from these data, opens the perspective that S100B may be regarded as a therapeutic target for these different diseases, which appear to share some common features reasonably attributable to neuroinflammation, regardless their origin. image
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–234 of 234
Dean, B., Gray, L. J., & Scarr, E. (2006) · Australian & New Zealand Journal of Psychiatry · doi:10.1111/j.1440-1614.2006.01777.x · Cited by 33
Vig, P. J. S., Hearst, S. M., Shao, Q., Lopez, M. E., Murphy, H. A., & Safaya, E. (2011) · The Cerebellum · doi:10.1007/s12311-011-0262-5 · Cited by 31
Kleindienst, A., Tolias, C. M., Corwin, F. D., Müller, C., Marmarou, A., Fatouros, P. P., & Bullock, M. R. (2005) · Journal of neurosurgery · doi:10.3171/jns.2005.102.6.1115 · Cited by 31
Serum S100B Protein is Specifically Related to White Matter Changes in Schizophrenia
Milleit, B., Smesny, S., Rothermundt, M., Preul, C., Schroeter, M. L., von Eiff, C., Ponath, G. D., Milleit, C., Sauer, H., & Gaser, C. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00033 · Cited by 31
Striatal Injury with 6-OHDA Transiently Increases Cerebrospinal GFAP and S100B
Batassini, C., Cunha, N. B., Tortorelli, L. S., Borsoï, M., Zanotto, C., Galland, F., Souza, T. M. E., Leite, M. C., & Gonçalves, C. (2015) · Neural Plasticity · doi:10.1155/2015/387028 · Cited by 30
Giovannoni, R., Maggio, N., Bianco, M. R., Cavaliere, C., Cirillo, G., Lavitrano, M., & Papa, M. (2007) · Neuron Glia Biology · doi:10.1017/s1740925x08000185 · Cited by 30
Viana, S., Valero, J., Rodrigues‐Santos, P., Couceiro, P., Silva, A. M., Carvalho, F. D., Ali, S. F., Ribeiro, C., & Pereira, F. C. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13682 · Cited by 30
Chang, M. S., Ariah, L. M., Marks, A., & Azmitia, E. C. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.043 · Cited by 28
Lambert, J., Ferreira, S., Gussekloo, J., Christiansen, L., Brysbaert, G., Slagboom, P. E., Cottel, D., Petit, T., Hauw, J. J., DeKosky, S. T., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001974 · Cited by 28
S100B raises the alert in subarachnoid hemorrhage
Chong, Z. Z. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0021 · Cited by 27
Expression of inflammatory markers in a genetic rodent model of depression
Strenn, N., Suchankova, P., Nilsson, S., Fischer, C. W., Wegener, G., Mathé, A. A., & Ekman, A. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.09.025 · Cited by 26
Qin, G., Gui, B., Xie, J., Chen, L., Chen, L., Cui, Z., Zhou, J., & Tan, G. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0999-5 · Cited by 26
Ca2+/S100 proteins inhibit the interaction of FKBP38 with Bcl-2 and Hsp90
Shimamoto, S., Tsuchiya, M., Yamaguchi, F., Kubota, Y., Tokumitsu, H., & Kobayashi, R. (2013) · Biochemical Journal · doi:10.1042/bj20130924 · Cited by 25
Lasič, E., Galland, F., Vardjan, N., Šribar, J., Križaj, I., Leite, M. C., Zorec, R., & Stenovec, M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13754 · Cited by 25
Satriano, A., Pluchinotta, F. R., Gazzolo, F., Serpero, L. D., & Gazzolo, D. (2016) · Early Human Development · doi:10.1016/j.earlhumdev.2016.12.005 · Cited by 25
Serum leptin and its relationship with psychopathology in schizophrenia
Nurjono, M., Neelamekam, S., & Lee, J. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.08.017 · Cited by 24
Vig, P. J. S., Lopez, M. E., Wei, J., D’Souza, D. R., Subramony, S. H., Henegar, J. R., & Fratkin, J. D. (2006) · PubMed · doi:10.1901/jaba.2006.23-166 · Cited by 22
Gambichler, T., Brown, V., Steuke, A. ‐., Schmitz, L., Stockfleth, E., & Susok, L. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14629 · Cited by 22
S100B is downregulated in the nuclear proteome of schizophrenia corpus callosum
Steiner, J., Schmitt, A., Schroeter, M. L., Bogerts, B., Falkai, P., Turck, C. W., & Martins‐de‐Souza, D. (2014) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0490-z · Cited by 21
Chronic Fluoxetine Treatment Changes S100B Expression During Postnatal Rat Brain Development
Bock, N., Koc, E., Alter, H., Roessner, V., Becker, A., Rothenberger, A., & Manzke, T. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0065 · Cited by 21
Wartchow, K. M., Tramontina, A. C., de Souza, D. F., Biasibetti, R., Bobermin, L. D., & Gonçalves, C. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1851-y · Cited by 20
Gülen, B., Serınken, M., Eken, C., Karcıoğlu, Ö., Küçükdağlı, Ö. T., Kılıç, E., Akpınar, G., Nogay, S., & Kuh, M. (2016) · Academic Emergency Medicine · doi:10.1111/acem.12973 · Cited by 20
S100B Modulates the Hemodynamic Response to Norepinephrine Stimulation
Tsoporis, J. N., Overgaard, C. B., Izhar, S., & Parker, T. G. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.145 · Cited by 20
Hao, M. M., Capoccia, E., Cirillo, C., Boesmans, W., & Berghe, P. V. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00042 · Cited by 20
Association of S100B Serum Levels with Metabolic Syndrome and its Components
Kheirouri, S., Ebrahimi, E., & Alizadeh, M. (2018) · Acta Médica Portuguesa · doi:10.20344/amp.9073 · Cited by 19
Bernardini, C., Lattanzi, W., Businaro, R., Leone, S., Corvino, V., Sorci, G., Lauro, G. M., FUMAGALLI, L., Donato, R., & MICHETTI, A. F. (2010) · Gene Expression · doi:10.3727/105221610x12718619643013 · Cited by 17
Self-citationThe Serum S100B Level as a Biomarker of Enteroglial Activation in Patients with Ulcerative Colitis
Çelikbilek, A., Çelikbilek, M., Sabah, S., Tanık, N., Börekçi, E., Doğan, S., Akin, Y., Baldane, S., Denız, K., Yılmaz, N., et al. (2014) · International Journal of Inflammation · doi:10.1155/2014/986525 · Cited by 15
Further evidence for a role of S100B in mood disorders: A human gene expression mega-analysis
Schroeter, M. L., Steiner, J., Schönknecht, P., & Mueller, K. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.02.021 · Cited by 15
S100B modulates growth factors and costimulatory molecules expression in cultured human astrocytes
Reali, C., Pillai, R., Saba, F., Cabras, S., Michetti, F., & Sogos, V. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.11.011 · Cited by 14
Self-citationCavalier, M. C., Melville, Z., Aligholizadeh, E., Raman, E. P., Yu, W., Fang, L., Alasady, M. J., Pierce, A. D., Wilder, P. T., MacKerell, A. D., et al. (2016) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798316005532 · Cited by 11
Immunocytochemical distribution of S-100 protein in patients with Down's syndrome
Michetti, F., Larocca, L. M., Rinelli, A., & Lauriola, L. (1990) · Acta Neuropathologica · doi:10.1007/bf00294606 · Cited by 10
Self-citationClementi, M. E., Sampaolese, B., & Giardina, B. (2016) · Current Aging Science · doi:10.2174/1874609809666160222112850 · Cited by 10
PARKINSON'S DISEASE PROGRESSION
Gruden, Sherstnev, V. V., Sewell, R. D. E., et al. (2014) · Journal of Neuroimmunology · Cited by 10
Ganina, K., Dugina, Y. L., Zhavbert, K. S., Ertuzun, I. А., Эпштейн, О. И., & Abdurasulova, I. N. (2016) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-016-0380-0 · Cited by 3
Cited by
Reactive astrocyte nomenclature, definitions, and future directions
Escartin, C., Galea, E., Lakatos, A., O’Callaghan, J. P., Petzold, G. C., Serrano-Pozo, A., Steinhäuser, C., Volterra, A., Carmignoto, G., Agarwal, A., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00783-4 · Cited by 2,513
Blood‐based biomarkers for Alzheimer's disease
Leuzy, A., Mattsson‐Carlgren, N., Palmqvist, S., Janelidze, S., Dage, J. L., & Hansson, O. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202114408 · Cited by 351
Cordaro, M., Cuzzocrea, S., & Crupi, R. (2020) · Antioxidants · doi:10.3390/antiox9030216 · Cited by 98
Farrell, C., Buhidma, Y., Mumford, P., Heywood, W. E., Hällqvist, J., Flores-Aguilar, L., Andrews, E. J., Rahimzadah, N., Taso, O. S., Doran, E., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02889-0 · Cited by 9
“S100B is a calcium-binding signalling protein that has an important role in neurodevelopment and brain damage response [27, 48].”
Metadata
- Authors
- Michetti, F., D'Ambrosi, N., Toesca, A., Puglisi, M. A., Serrano, A., Marchese, E., Corvino, V., & Geloso, M. C.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2018-11-12
- Volume
- 148
- Issue
- 2
- Pages
- 168-187
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2888257210
- Cited by
- 410
- References
- 234
- FWCI
- 7.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.